Arrowhead Pharmaceuticals, Inc. annual free cash flow for fiscal 2025 was $157 million, compared with -$604 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $157M | ($604M) | ($331M) | ($189M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Free Cash Flow | $82M | $11M | $13M | ($157M) | $455M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More ARWR metrics: Revenue · Operating Income · Net Income · EPS
All ARWR financial statements → Interactive ARWR charts →
About TickerBase · Data methodology & sources